Results 191 to 200 of about 179,841 (273)

BTM Topic Modeling Approach to Named Entity Linking

open access: yesJournal of Physics: Conference Series, 2018
Menglu You   +4 more
openaire   +1 more source

How to ‘survive’ after graduating in science or engineering: Becoming an academic administrator

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
Abstract This is the eighth article in the series ‘Survival Skills for Scientists’; previous papers were published in the Journal of Materials Education. Here I describe my views, based partly on personal experience, about pursuing an alternative career path within academia: becoming an administrator (e.g., Department Chair, Dean, Vice‐President ...
Federico Rosei
wiley   +1 more source

From literature to biodiversity data: mining arthropod organismal traits with machine learning. [PDF]

open access: yesBiodivers Data J
Cornelius J   +5 more
europepmc   +1 more source

Post‐LECA Origin and Diversification of an Axonemal Outer Arm Dynein Motor

open access: yesCytoskeleton, EarlyView.
ABSTRACT Dyneins were present in the last eukaryotic common ancestor (LECA) and play key roles in eukaryotic biology. Axonemal dyneins form the inner and outer arms that power ciliary beating, and it has long been recognized that outer arms in some organisms contain two different heavy chain motors, whereas those from other species contain a third unit
Stephen M. King
wiley   +1 more source

SNOMED CT entity linking challenge. [PDF]

open access: yesJ Am Med Inform Assoc
Davidson R   +11 more
europepmc   +1 more source

PharmVar GeneFocus: CYP1A2—Clinical Impact, Genetic Variation, and Updated Nomenclature

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP1A2 gene. CYP1A2 plays a crucial role in the biotransformation of several commonly used drugs, including antipsychotics, antidepressants, anxiolytics, and methylxanthines.
Katalin Monostory   +13 more
wiley   +1 more source

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Tijana Stojanović   +4 more
wiley   +1 more source

Bangla MedER: Multi-BERT ensemble approach for the recognition of Bangla medical entity. [PDF]

open access: yesPLoS One
Aurpa TT   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy